IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.26−0.14 (-4.12%)
Close on Nov 17, 2026Market cap $24.02MP/E –Yield –
Immutep operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -A$55.46M. The highest annual figure on record is -A$7.78M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$55.46M | – |
| FY2025 | Jun 30, 2025 | -A$62.05M | – |
| FY2024 | Jun 30, 2024 | -A$34.82M | – |
| FY2023 | Jun 30, 2023 | -A$35.36M | – |
| FY2022 | Jun 30, 2022 | -A$30.23M | – |
| FY2021 | Jun 30, 2021 | -A$17.64M | – |
| FY2020 | Jun 30, 2020 | -A$10.84M | – |
| FY2019 | Jun 30, 2019 | -A$15.29M | – |
| FY2018 | Jun 30, 2018 | -A$7.78M | – |
| FY2017 | Jun 30, 2017 | -A$8.51M | – |
| FY2016 | Jun 30, 2016 | -A$11.31M | – |
See a number that looks wrong?